Compounds > levofloxacin
Page last updated: 2024-09-04

levofloxacin and Carcinoma, Squamous Cell

levofloxacin has been researched along with Carcinoma, Squamous Cell in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Atas, MN; Aydemir, L; Cakmakoglu, B; Ergen, A; Ertugrul, B; Iplik, ES; Kasarci, G; Ulusan, M1
Liu, CY; Salloum, R; Weise, AM1

Other Studies

2 other study(ies) available for levofloxacin and Carcinoma, Squamous Cell

ArticleYear
Levofloxacin might be safe to use for OSCC patients.
    Medical oncology (Northwood, London, England), 2021, Jun-25, Volume: 38, Issue:8

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Cisplatin; Humans; Levofloxacin; Mouth Neoplasms; Tongue Neoplasms

2021
Possible case of levofloxacin-induced thrombocytopenia.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2011, Jan-01, Volume: 68, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Carcinoma, Squamous Cell; Female; Humans; Levofloxacin; Mouth Neoplasms; Ofloxacin; Platelet Count; Pneumonia, Bacterial; Thrombocytopenia

2011